Building envelope solutions provider Carlisle Companies (NYSE:CSL) fell short of the market’s revenue expectations in Q1 ...

Carlisle Companies Inc (CSL) reports a resilient quarter with margin expansion and strategic product launches amid revenue decline.

After an antitrust review knocked 2021’s biggest biopharma buyout off course in May, CSL’s $11.7 billion deal for Swiss iron deficiency specialist Vifor Pharma appears to be back on track. Tuesday, ...

CSL is near decade lows. Can it ever climb back? The post Can the beaten-down CSL share price ever reach $300 again? appeared ...

Earlier this year, BMW debuted the M4 CS, a car designed to sit between the Competition Package and the ultra-hardcore M4 GTS. Of course, bringing back the CS designation, which stands for Coupe Sport ...